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Dear Editor
Modulation of Human Basophil
Degranulation by Geranylgeranyl
Compounds
Recent experimental studies have shown that the ba-
sophil is critical for a subtype of anaphylaxis or IgE-
mediated very late-phase skin inflammation.1 Motility
and activation of basophils are known to be regulated
by various endogenous andor exogenous sub-
stances. The panel of known such basophil-directed
molecules is expanding. One important candidate
may be geranylgeranyl compounds, which were in-
itially demonstrated to be protectors of the gastric
mucosa.2 These compounds have also demonstrated
protective actions in situations that are often hazard-
ous to the host. In rodent studies, geranylgeranylace-
tone (GGA) suppressed the development of several
inflammatory reactions and enhanced tissue regen-
eration in vivo.2,3 However, the effects of GGA on al-
lergic effectors and immunologic reactions have not
been fully clarified.
In this study, we assessed the pharmacological ac-
tions of GGA and related compounds on basophil de-
granulation, detected as release of histamine. Baso-
phils were obtained from non allergic volunteers by
dextran sedimentation of whole blood. Cells were
preincubated with GGA (Wako Pure Chemicals,
Osaka, Japan) for 15 min at 37℃, washed and then
stimulated with a secretagogue for 45 min.4
Degranulation of basophils by polyclonal anti-IgE
antibody (MBL, Nagoya, Japan ) and by phorbol
myristate acetate ( PMA) ( Sigma, St. Louis, MO,
USA) was significantly enhanced by preincubation of
cells for 15 min with GGA at 1.4 or 2.7 mM (Fig. 1a).
Similar results were observed for highly pure baso-
phils (purity >95%; prepared by Percoll gradient cen-
trifugation followed by negative MACS selection), in-
dicating that GGA acts directly on basophils. On the
other hand, GGA showed no clear effect on basophil
degranulation by a chemokine, monocyte chemoat-
tractant protein (MCP)-1 or Ca ionophore A23187. As
shown in Figure 1b, up to 15 min of incubation of ba-
sophils with GGA alone at 2.7 mM did not induce re-
lease of histamine. However, 30 min or longer incuba-
tion resulted in higher, 15 to 20% histamine release,
suggesting that GGA at this concentration might
damage basophils in a time-dependent manner. The
extent of enhancement of IgE-mediated basophil de-
granulation by GGA was mild compared to that by IL-
3, and GGA did not show additive augmentation of
histamine release by IL-3-treated basophils (Fig. 1c).
As shown in Figure 1d, another geranylgeranyl com-
pound, geranylgeraniol (Sigma), also upregulated ba-
sophil histamine release evoked by anti-IgE antibody
or PMA. On the other hand, compounds having
smaller structures, such as geranylacetone and farne-
sol, showed no effect on basophil degranulation (data
not shown). Statins inhibit intracellular geranylger-
anylation, resulting in suppression of the activation
profiles of inflammatory cells, 5-7 and basophil de-
granulation in response to anti-IgE antibody or PMA
was significantly suppressed by preincubation with
simvastatin at 50 μM (Fig. 1e).
Geranylgeranyl compounds are reported to be in-
volved in intracellular signal cascades in various cells,
including mast cell activation evoked by IgE
crosslinkage.5-7 Our present finding that exogenously
added GGA can enhance basophil activation suggests
that GGA enters basophils and then behaves as a sub-
strate in the cell activation pathway. Simvastatin,
which can inhibit intracellular geranylgeranylation,
suppressed basophil degranulation triggered by anti-
IgE antibody and PMA, but not A23187. This finding
coincides with our results that GGA augmented baso-
phil degranulation evoked by anti-IgE antibody and
PMA, but not A23187 or MCP-1, suggesting that pro-
tein kinase C or related molecule(s) may be the tar-
get of GGA. It appears that geranyl and farnesyl com-
pounds are not involved in the above pathway in ba-
sophils.
GGA’s various novel actions are being unveiled
through recent experimental approaches. Mostly
based on murine studies, this compound is able to
suppress vicious inflammatory disorders of the skin
or visceral organs, including pulmonary inflammation
induced by gefitinib, an inhibitor of epidermal growth
factor receptor-mediated signals.3 It is thought that
one of main in vivo effects of GGA is induction of
tissue-stabilizing heat shock proteins.2,3 In vivo stud-
ies have so far tested GGA at μM to mM concentra-
tions and have found increases in those proteins and
changes in cell fate.8,9 Our present findings suggest
that GGA at relatively high concentrations can also
exert acute effects on cellular functions and enhance
the activation of basophils evoked by certain secre-
tagogues. Although the in vivo significance of our
findings and the whole aspect of the biologic actions
of GGA remain unclear, elucidation of the precise
roles of this compound in allergies and other tissue-
damaging disorders is of special interest in light of its
characteristic host-protecting properties.
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Fig.　1　Modulation of basophil histamine release by geranylgeranyl and related compounds. (a) Basophil preparations were
preincubated with and without GGA and then stimulated with various secretagogues. GGA at 1.4 and 2.7 mM corresponds to 0.5 
and 1 μl/ml, respectively. Histamine release was expressed as a percentage of the total cellular histamine after subtracting 
spontaneous release (usually <5%). Data are the mean ± SEM of three to six separate experiments. *p ≤ 0.05, versus corre-
sponding values of cells not preincubated with GGA. (b) Baseline histamine release by basophils after treatment with GGA. 
Cells were preincubated with GGA at 1 μl/ml for the indicated times, washed and then incubated without any secretagogue for 
45 min. Data shown are representative of three separate experiments that generated similar results. (c) Priming effects of GGA 
and IL-3 on basophil degranulation. Cells were preincubated with and without GGA for 15 min, washed and then incubated with 
and without IL-3 before stimulation with anti-IgE antibody. Data are the mean ± SEM (n = 3). *p < 0.05 versus corresponding 
value of cells not preincubated with GGA. †p < 0.05 versus corresponding value of IL-3-untreated cells. (d) Effect of geranyl-
geraniol on basophil histamine release. The indicated concentration of this compound (0.5 μl/ml, 1.5 mM) did not induce non-
specifi c histamine release. Data are the mean ± SEM (n = 3). *p < 0.05 versus corresponding value of cells not preincubated
with geranylgeraniol. (e) Simvastatin suppressed basophil degranulation. Basophils were preincubated with and without simvas-
tatin for 15 min at 37˚C, washed and then stimulated with anti-IgE antibody or PMA for 45 min. Data are the mean ± SEM 
(n = 4). *p < 0.05, versus corresponding value of cells untreated with simvastatin.
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GGA Modulates Basophil Activation
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